rs13167280

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198253.3(TERT):​c.1770-24C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,609,006 control chromosomes in the GnomAD database, including 13,259 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1122 hom., cov: 33)
Exomes 𝑓: 0.13 ( 12137 hom. )

Consequence

TERT
NM_198253.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0530

Publications

31 publications found
Variant links:
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dyskeratosis congenita, autosomal dominant 2
    Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma, cutaneous malignant, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 5-1280362-G-A is Benign according to our data. Variant chr5-1280362-G-A is described in ClinVar as Benign. ClinVar VariationId is 1274097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERTNM_198253.3 linkc.1770-24C>T intron_variant Intron 3 of 15 ENST00000310581.10 NP_937983.2 O14746-1
TERTNM_001193376.3 linkc.1770-24C>T intron_variant Intron 3 of 14 NP_001180305.1 O14746-3
TERTNR_149162.3 linkn.1849-24C>T intron_variant Intron 3 of 12
TERTNR_149163.3 linkn.1849-24C>T intron_variant Intron 3 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TERTENST00000310581.10 linkc.1770-24C>T intron_variant Intron 3 of 15 1 NM_198253.3 ENSP00000309572.5 O14746-1

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16304
AN:
152132
Hom.:
1106
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0357
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.110
Gnomad ASJ
AF:
0.129
Gnomad EAS
AF:
0.208
Gnomad SAS
AF:
0.0956
Gnomad FIN
AF:
0.151
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.125
GnomAD2 exomes
AF:
0.127
AC:
31040
AN:
243860
AF XY:
0.126
show subpopulations
Gnomad AFR exome
AF:
0.0324
Gnomad AMR exome
AF:
0.109
Gnomad ASJ exome
AF:
0.124
Gnomad EAS exome
AF:
0.209
Gnomad FIN exome
AF:
0.158
Gnomad NFE exome
AF:
0.135
Gnomad OTH exome
AF:
0.130
GnomAD4 exome
AF:
0.126
AC:
183570
AN:
1456754
Hom.:
12137
Cov.:
32
AF XY:
0.126
AC XY:
91120
AN XY:
724744
show subpopulations
African (AFR)
AF:
0.0328
AC:
1098
AN:
33432
American (AMR)
AF:
0.112
AC:
4993
AN:
44562
Ashkenazi Jewish (ASJ)
AF:
0.127
AC:
3325
AN:
26096
East Asian (EAS)
AF:
0.160
AC:
6328
AN:
39648
South Asian (SAS)
AF:
0.100
AC:
8606
AN:
86074
European-Finnish (FIN)
AF:
0.156
AC:
7926
AN:
50850
Middle Eastern (MID)
AF:
0.156
AC:
754
AN:
4840
European-Non Finnish (NFE)
AF:
0.129
AC:
143076
AN:
1111078
Other (OTH)
AF:
0.124
AC:
7464
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7716
15432
23147
30863
38579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5082
10164
15246
20328
25410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16342
AN:
152252
Hom.:
1122
Cov.:
33
AF XY:
0.107
AC XY:
7943
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0360
AC:
1497
AN:
41566
American (AMR)
AF:
0.109
AC:
1672
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
448
AN:
3470
East Asian (EAS)
AF:
0.208
AC:
1074
AN:
5168
South Asian (SAS)
AF:
0.0963
AC:
465
AN:
4828
European-Finnish (FIN)
AF:
0.151
AC:
1598
AN:
10602
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.134
AC:
9116
AN:
68012
Other (OTH)
AF:
0.135
AC:
286
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
741
1482
2223
2964
3705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
1374
Bravo
AF:
0.103
Asia WGS
AF:
0.179
AC:
621
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.4
DANN
Benign
0.35
PhyloP100
-0.053
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13167280; hg19: chr5-1280477; COSMIC: COSV57198812; API